vidarabine phosphate and B-Cell Leukemia

vidarabine phosphate has been researched along with B-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bashey, A; Baxter-Lowe, LA; Farag, S; Isola, L; Johnson, J; Kelly, M; Linker, C; McCarty, J; Owzar, K; Shea, T; Westervelt, P	1

Trials

1 trial(s) available for vidarabine phosphate and B-Cell Leukemia

Article	Year
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine Phosphate	2011

Article

Year

Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:9

Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine Phosphate

2011